CN115444899A - First moxibustion method for treating sub-health chronic fatigue syndrome - Google Patents

First moxibustion method for treating sub-health chronic fatigue syndrome Download PDF

Info

Publication number
CN115444899A
CN115444899A CN202211179022.XA CN202211179022A CN115444899A CN 115444899 A CN115444899 A CN 115444899A CN 202211179022 A CN202211179022 A CN 202211179022A CN 115444899 A CN115444899 A CN 115444899A
Authority
CN
China
Prior art keywords
parts
moxibustion
ginger
chronic fatigue
fatigue syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211179022.XA
Other languages
Chinese (zh)
Inventor
霍莉莉
石程
高晓悦
何古文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI TCM-INTEGRATED HOSPITAL
Original Assignee
SHANGHAI TCM-INTEGRATED HOSPITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI TCM-INTEGRATED HOSPITAL filed Critical SHANGHAI TCM-INTEGRATED HOSPITAL
Priority to CN202211179022.XA priority Critical patent/CN115444899A/en
Publication of CN115444899A publication Critical patent/CN115444899A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/06—Devices for heating or cooling such points within cell-life limits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a first moxibustion method for treating sub-health chronic fatigue syndrome, which comprises the following specific steps: s1, material preparation: firstly, preparing moxibustion powder, moxa cone and ginger velvet respectively, wherein the moxibustion powder comprises the following components in parts by weight: 0.6 to 1.6 parts of corydalis tuber, 0.6 to 1.6 parts of prepared nutgrass galingale rhizome, 1.2 to 2.2 parts of angelica, 0.6 to 1.7 parts of earthworm, 1.7 to 2.8 parts of pubescent angelica root, 1 to 2 parts of astragalus root, 0.3 to 0.7 part of cinnamon, 0.3 to 0.7 part of common monkshood mother root, 0.5 to 1.5 parts of sanchi and 1.5 to 2.5 parts of malaytea scurfpea fruit; s2, carrying out first moxibustion: spreading a layer of moxibustion powder around navel at 4cm in and near navel, covering with a piece of mulberry paper, spreading ginger down on the mulberry paper in round cake shape, extruding a groove at the center above the ginger down, placing moxa column in the groove in shape of Chinese character 'tian', igniting the moxa column, performing first moxibustion, removing ginger down, and removing medicinal mud. The invention can more quickly and effectively treat the chronic fatigue syndrome by stimulating the skin of the navel of the human body, and has better treatment effect.

Description

First moxibustion method for treating sub-health chronic fatigue syndrome
Technical Field
The invention relates to the technical field of chronic fatigue syndrome treatment, in particular to a first moxibustion method for treating sub-health chronic fatigue syndrome.
Background
Chronic fatigue syndrome, manifested as: fatigue, weakness, energy deficiency, muscle and joint soreness, insomnia, dreaminess, inappetence, loose stool, constipation, aversion to cold and heat, low mood, memory decline, and slow reaction.
Chinese patent publication No. CN101607027A discloses an application of a Chinese medicinal composition in preparing a medicament for treating chronic fatigue syndrome. The traditional Chinese medicine composition is composed of 9 traditional Chinese medicines such as wild jujube, mulberry and the like, has the effects of nourishing yin, soothing nerves and regulating qi and blood, and can also treat sub-health and exercise-induced fatigue caused by overwork belonging to chronic fatigue syndrome.
However, the treatment is carried out by taking the medicine, the patient is uncomfortable when taking the medicine, and in order to more comfortably treat the sub-health chronic fatigue syndrome, the invention provides the chronic fatigue syndrome, which is represented as follows: fatigue, weakness, energy deficiency, muscle and joint soreness, insomnia, dreaminess, inappetence, loose stool, constipation, aversion to cold and heat, low mood, memory decline, and slow reaction.
Chinese patent publication No. CN101607027A discloses an application of a Chinese medicinal composition in preparing a medicament for treating chronic fatigue syndrome. The traditional Chinese medicine composition is prepared from 9 traditional Chinese medicines such as wild jujube, mulberry and the like, has the effects of nourishing yin, soothing nerves and regulating qi and blood, and can also treat sub-health and exercise-induced fatigue caused by overwork belonging to chronic fatigue syndrome.
However, the treatment is carried out by taking the medicine, the patient can feel uncomfortable when taking the medicine, and the invention provides a first moxibustion method for treating the sub-health chronic fatigue syndrome in order to more comfortably treat the sub-health chronic fatigue syndrome.
Disclosure of Invention
The invention provides a first moxibustion method for treating sub-health chronic fatigue syndrome, which aims to solve the problems in the background technology.
In order to achieve the purpose, the invention adopts the following technical scheme:
a first moxibustion method for treating sub-health chronic fatigue syndrome comprises the following specific steps:
s1, material preparation: firstly, preparing moxibustion powder, moxa cone and ginger velvet respectively, wherein the moxibustion powder comprises the following components in parts by weight: 0.6 to 1.6 parts of corydalis tuber, 0.6 to 1.6 parts of prepared nutgrass galingale rhizome, 1.2 to 2.2 parts of angelica, 0.6 to 1.7 parts of earthworm, 1.7 to 2.8 parts of pubescent angelica root, 1 to 2 parts of astragalus root, 0.3 to 0.7 part of cinnamon, 0.3 to 0.7 part of common monkshood mother root, 0.5 to 1.5 parts of pseudo-ginseng and 1.5 to 2.5 parts of malaytea scurfpea fruit;
s2, carrying out first moxibustion: spreading a layer of moxibustion powder around navel at 4cm in and near navel to cover conception vessel, kidney meridian and spleen meridian, covering with a piece of mulberry paper, spreading ginger down on the mulberry paper in round cake shape, extruding a groove at the center above the ginger down, placing moxa column in the groove in "field" shape, igniting the moxa column, performing first moxibustion, removing ginger down, and removing medicinal mud.
As a further improvement scheme of the technical scheme: the moxibustion powder comprises the following components in parts by weight: 1 part of corydalis tuber, 1 part of prepared rhizoma cyperi, 1.5 parts of angelica, 1 part of earthworm, 2 parts of radix angelicae pubescentis, 1.5 parts of astragalus mongholicus, 0.5 part of cinnamon, 0.5 part of monkshood, 1 part of pseudo-ginseng and 2 parts of fructus psoraleae.
As a further improvement scheme of the technical scheme: the moxibustion powder comprises the following components in parts by weight: 1.5 parts of corydalis tuber, 1.5 parts of prepared rhizoma cyperi, 2 parts of angelica, 1.5 parts of earthworm, 2.5 parts of pubescent angelica root, 2 parts of astragalus, 0.6 part of cinnamon, 0.6 part of common monkshood mother root, 1.5 parts of pseudo-ginseng and 2.5 parts of malaytea scurfpea fruit.
As a further improvement scheme of the technical scheme: the preparation method of the moxa cone comprises the following steps: 100g of fine, soft and pure moxa is selected and is twisted into a plurality of long cylinders with the length of 4 cm.
As a further improvement scheme of the technical scheme: the preparation method of the ginger velvet comprises the following steps: peeling about 3000g of fresh ginger, preparing ginger floss, squeezing out excessive water, and keeping the ginger floss soft and moist.
As a further improvement scheme of the technical scheme: a layer of moxibustion powder is circularly spread around the navel at the center and 4cm near the navel of a human body, and the dosage of the moxibustion powder is 2g.
As a further improvement scheme of the technical scheme: the length of the mulberry paper is 15cm, the width of the mulberry paper is 15cm, and the paper size of the mulberry paper can be adjusted according to the back body type of a patient.
As a further improvement scheme of the technical scheme: in S2, when the ginger velvet is laid on the mulberry paper, a distance of about 2cm is required to be reserved between the ginger velvet and the edge of the mulberry paper.
As a further improvement scheme of the technical scheme: spreading the ginger velvet on the mulberry paper in a round cake shape, wherein the thickness of the ginger velvet is required to be uniform from top to bottom and is 1.3-1.7cm.
As a further improvement scheme of the technical scheme: the time for each nail moxibustion is 50-70min.
Compared with the prior art, the invention has the beneficial effects that:
(1) The prepared moxibustion powder prepared from rhizoma corydalis, prepared rhizoma cyperi, angelica sinensis, lumbricus, radix angelicae pubescentis, astragalus membranaceus, cinnamon, monkshood, pseudo-ginseng and fructus psoraleae can stimulate navel skin of a human body and is used for treating chronic fatigue syndrome;
(2) The mulberry paper is laid on the moxibustion powder, and the ginger velvet is added, so that the stimulation of the stimulating ginger velvet improving moxibustion powder to the skin acupuncture points of the navel of a human body mainly comprises the conception vessel, the kidney channel and the spleen channel;
(3) The ignited moxa cone can improve the surface temperature and enlarge pores while relaxing the body by performing moxa therapy on acupuncture points on the body surface, so that the absorption effect of the acupuncture points on moxibustion powder is improved;
in conclusion, the traditional Chinese medicine composition can quickly and effectively treat the chronic fatigue syndrome by stimulating the skin of the navel of a human body, and has better treatment effect.
The foregoing description is only an overview of the technical solutions of the present invention, and in order to make the technical solutions of the present invention more clearly understood and to implement them in accordance with the contents of the description, the following detailed description is given with reference to the preferred embodiments of the present invention and the accompanying drawings. The detailed description of the present invention is given in detail by the following examples and the accompanying drawings.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this application, illustrate embodiment(s) of the invention and together with the description serve to explain the invention without limiting the invention. In the drawings:
FIG. 1 is a schematic structural view of a first moxibustion method for treating sub-health chronic fatigue syndrome, in which ginger velvet and moxa cone are placed on mulberry paper;
fig. 2 is a flow chart of the first moxibustion method for treating sub-health chronic fatigue syndrome according to the present invention.
Detailed Description
The principles and features of this invention are described below in conjunction with the following drawings, which are set forth to illustrate, but are not to be construed to limit the scope of the invention. The invention is described in more detail in the following paragraphs by way of example with reference to the accompanying drawings. Advantages and features of the present invention will become apparent from the following description and from the claims. It is to be noted that the drawings are in a very simplified form and are not to precise scale, which is merely for the purpose of facilitating and distinctly claiming the embodiments of the present invention.
Referring to fig. 1-2, in an embodiment of the present invention, a method for nail moxibustion for treating sub-health chronic fatigue syndrome includes the following steps:
s1, material preparation: firstly, preparing moxibustion powder, moxa cone and ginger velvet respectively, wherein the moxibustion powder comprises the following components in parts by weight: 1 part of corydalis tuber, 1 part of prepared rhizoma cyperi, 1.5 parts of angelica, 1 part of earthworm, 2 parts of radix angelicae pubescentis, 1.5 parts of astragalus mongholicus, 0.5 part of cinnamon, 0.5 part of monkshood, 1 part of pseudo-ginseng and 2 parts of fructus psoraleae, and the medicines are mixed, subjected to superfine grinding and sealed for later use;
the preparation method of the moxa cone comprises the following steps: selecting 100g of fine, soft and pure moxa, and rubbing into a plurality of long cylinders with the length of 4 cm;
the preparation method of the ginger velvet comprises the following steps: peeling about 3000g of fresh ginger, preparing ginger floss, squeezing out excessive water, and keeping the ginger floss soft and moist;
s2, first moxibustion operation
A layer of moxibustion powder (about 2 g) is annularly scattered around the navel in the middle and 4cm beside the navel of a human body, namely the moxibustion powder covers the conception vessel, the kidney channel and the spleen channel, and then a piece of mulberry paper with the length of about 15cm and the width of about 15cm is covered on the moxibustion powder, so that the size of the paper can be adjusted according to the body type of the abdomen of a patient. The ginger velvet is spread on mulberry paper in a cake shape (the radius of the cake is adjusted according to the size of the abdomen of a human body), the upper part and the lower part are required to be uniform, and the thickness is about 1.5cm. Extruding a groove in the center above the ginger velvet, placing the moxa cone in a shape like a Chinese character 'tian' in the groove, igniting the moxa cone, performing nail moxibustion, and combusting for 2 strong. After the moxibustion is completed, the ginger velvet is taken down, the medicine mud is wiped off, and the first moxibustion is performed for about 60min each time.
Only the points of difference from the first embodiment will be described below, wherein the same method as in the first embodiment is not repeatedly described. The second embodiment is different from the first embodiment in that:
the moxibustion powder comprises the following components in parts by weight: 1.5 parts of corydalis tuber, 1.5 parts of prepared rhizoma cyperi, 2 parts of angelica, 1.5 parts of earthworm, 2.5 parts of pubescent angelica root, 2 parts of astragalus, 0.6 part of cinnamon, 0.6 part of common monkshood mother root, 1.5 parts of pseudo-ginseng and 2.5 parts of malaytea scurfpea fruit.
Clinical cases
Subject: 20 sub-healthy consumptive disease patients, age 20-60 years, mean age 35.6 years, symptoms: (1) short-term memory decline or inability to concentrate; (2) sore throat; (3) lymph node pain; (4) muscular soreness; (5) joint pain without redness and swelling; (6) new onset headache; (7) inability to recover energy after sleep; (8) the physical discomfort lasts for 24 hours after physical or mental labor.
(2) Treatment: 20 patients are treated by the longjia moxibustion therapy for treating the sub-health chronic fatigue syndrome, 1 time per week, 4 times as 1 treatment course, and 1 treatment course is total. Other medicines are forbidden during the treatment period, and the curative effect is judged after the treatment period is finished.
(3) The clinical curative effect is as follows:
clinical cure (symptoms disappear completely and can not be adapted, 4 cases are required for normal social life and work rhythm, obvious effect (most of clinical symptoms disappear or are improved obviously, normal work and life are not influenced basically 5 cases), progress (clinical symptoms are improved to some extent, the time is light and the time is heavy 1 case, ineffective (clinical symptoms are not reduced or aggravated) 0 case, and total effective rate is 100 percent, and no toxic or side effect and adverse effect are found in the clinical test process.
The foregoing is merely a preferred embodiment of the invention and is not intended to limit the invention in any manner; the present invention may be readily implemented by those of ordinary skill in the art as illustrated in the accompanying drawings and described above; however, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the scope of the invention; meanwhile, any equivalent changes, modifications and evolutions made to the above embodiments according to the substantial technology of the present invention are still within the protection scope of the technical solution of the present invention.

Claims (10)

1. A first moxibustion method for treating sub-health chronic fatigue syndrome is characterized by comprising the following specific steps:
s1, material preparation: firstly, preparing moxibustion powder, moxa cone and ginger velvet respectively, wherein the moxibustion powder comprises the following components in parts by weight: 0.6 to 1.6 parts of corydalis tuber, 0.6 to 1.6 parts of prepared nutgrass galingale rhizome, 1.2 to 2.2 parts of angelica, 0.6 to 1.7 parts of earthworm, 1.7 to 2.8 parts of pubescent angelica root, 1 to 2 parts of astragalus root, 0.3 to 0.7 part of cinnamon, 0.3 to 0.7 part of common monkshood mother root, 0.5 to 1.5 parts of pseudo-ginseng and 1.5 to 2.5 parts of malaytea scurfpea fruit;
s2, performing first moxibustion: spreading a layer of moxibustion powder around navel at 4cm in and near navel to cover conception vessel, kidney meridian and spleen meridian, covering with a piece of mulberry paper, spreading ginger down on the mulberry paper in round cake shape, extruding a groove at the center above the ginger down, placing moxa column in the groove in "field" shape, igniting the moxa column, performing first moxibustion, removing ginger down, and removing medicinal mud.
2. The first moxibustion method for treating sub-health chronic fatigue syndrome according to claim 1, characterized in that the moxibustion powder comprises the following components in parts by weight: 1 part of corydalis tuber, 1 part of prepared nutgrass galingale rhizome, 1.5 parts of angelica, 1 part of earthworm, 2 parts of pubescent angelica root, 1.5 parts of astragalus, 0.5 part of cinnamon, 0.5 part of common monkshood mother root, 1 part of pseudo-ginseng and 2 parts of malaytea scurfpea fruit.
3. The first moxibustion method for treating sub-health chronic fatigue syndrome according to claim 1, characterized in that the moxibustion powder comprises the following components in parts by weight: 1.5 parts of corydalis tuber, 1.5 parts of prepared rhizoma cyperi, 2 parts of angelica, 1.5 parts of earthworm, 2.5 parts of pubescent angelica root, 2 parts of astragalus, 0.6 part of cinnamon, 0.6 part of common monkshood mother root, 1.5 parts of pseudo-ginseng and 2.5 parts of malaytea scurfpea fruit.
4. The first moxibustion method for treating sub-health chronic fatigue syndrome according to claim 1, wherein the preparation method of the moxa cone comprises the following steps: 100g of fine, soft and pure moxa is selected and is twisted into a plurality of long cylinders with the length of 4 cm.
5. The method for nail moxibustion for treating sub-health chronic fatigue syndrome according to claim 1, wherein the ginger velvet is prepared by the following steps: peeling about 3000g of fresh ginger, preparing ginger velvet, squeezing out excessive water, and keeping the ginger velvet soft and moist.
6. The method for Jia moxibustion capable of treating sub-health chronic fatigue syndrome as claimed in claim 1, wherein a layer of moxibustion powder is sprinkled in the middle and 4cm around the navel of human body, and the dosage of moxibustion powder is 2g.
7. The method for Jia moxibustion therapy for sub-health chronic fatigue syndrome as claimed in claim 1, wherein the length of mulberry paper is 15cm, the width is 15cm, and the size of mulberry paper can be adjusted according to the back size of the patient.
8. The method of claim 1, wherein in step S2, ginger velvet is laid on mulberry paper at a distance of about 2cm from the edges of the mulberry paper.
9. The method for moxibustion of the nail for treatment of chronic fatigue syndrome in sub-health state as claimed in claim 1, wherein ginger down is spread on the mulberry paper in a cake shape, and the thickness of ginger down is required to be uniform from top to bottom and is 1.3-1.7cm.
10. The method of claim 1, wherein the first moxibustion time is 50-70min.
CN202211179022.XA 2022-09-26 2022-09-26 First moxibustion method for treating sub-health chronic fatigue syndrome Pending CN115444899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211179022.XA CN115444899A (en) 2022-09-26 2022-09-26 First moxibustion method for treating sub-health chronic fatigue syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211179022.XA CN115444899A (en) 2022-09-26 2022-09-26 First moxibustion method for treating sub-health chronic fatigue syndrome

Publications (1)

Publication Number Publication Date
CN115444899A true CN115444899A (en) 2022-12-09

Family

ID=84306643

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211179022.XA Pending CN115444899A (en) 2022-09-26 2022-09-26 First moxibustion method for treating sub-health chronic fatigue syndrome

Country Status (1)

Country Link
CN (1) CN115444899A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116712324A (en) * 2023-04-27 2023-09-08 云南郑保制药有限公司 Notoginseng moxibustion plaster

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716409A (en) * 2012-07-02 2012-10-10 裴保法 Traditional Chinese medicine composition for tonifying qi and nourishing blood
CN107551236A (en) * 2017-08-22 2018-01-09 北京未医堂健康科技有限公司 End ball moxibustion prescription and its preparation method and application
CN109589396A (en) * 2018-12-17 2019-04-09 郭宇欣 A kind of Moxa conditioning essential oil and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716409A (en) * 2012-07-02 2012-10-10 裴保法 Traditional Chinese medicine composition for tonifying qi and nourishing blood
CN107551236A (en) * 2017-08-22 2018-01-09 北京未医堂健康科技有限公司 End ball moxibustion prescription and its preparation method and application
CN109589396A (en) * 2018-12-17 2019-04-09 郭宇欣 A kind of Moxa conditioning essential oil and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
郑兆俭: "背部走罐与中药外敷治疗慢性疲劳综合征35例", 中医外治杂志, vol. 11, no. 01, pages 31 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116712324A (en) * 2023-04-27 2023-09-08 云南郑保制药有限公司 Notoginseng moxibustion plaster
CN116712324B (en) * 2023-04-27 2024-04-23 云南郑保制药有限公司 Notoginseng moxibustion plaster

Similar Documents

Publication Publication Date Title
CN101912572A (en) Multi-effect external plaster
CN105381085A (en) Functional traditional Chinese medicine pillow
CN115444899A (en) First moxibustion method for treating sub-health chronic fatigue syndrome
CN104208415A (en) Traditional Chinese medicine for treatment of arrhythmia
CN109303906A (en) It is a kind of for warming and activating meridian, the long-acting moxibustion plaster of damp dispelling and pain relieving and preparation method thereof
CN112675281A (en) Foot bath soup for treating depression and insomnia
CN106110216A (en) Treat neurasthenic Chinese medicinal formulae
CN106075311A (en) One is used for treating neurasthenic Chinese medicine composition
CN103989999A (en) Traditional Chinese medicinal preparation for treating spinal tuberculosis and preparation method thereof
CN103800730A (en) Foot bath powder
CN115400183A (en) Dragon moxibustion method for treating sub-health chronic fatigue syndrome
CN106620255A (en) Traditional Chinese medicine for tonifying kidney and spleen
CN105878627A (en) Traditional Chinese medicine formula for treating myopic disease
CN104971204A (en) Kidney-tonifying and resuscitation-inducing pill and medicinal strip cooperating with acupuncture for treating neurological tinnitus
CN105031804A (en) Chinese medicinal cap capable of treating migraine
CN104983978A (en) External-use medicine composition for treating burn, external-use ointment for treating burn and preparing method of external-use ointment
CN104645229B (en) A kind of five-element's dipping dissipates and preparation method
Ji et al. The use of traditional Chinese medicine internally and externally combined with auricular acupuncture point bloodletting in the treatment of vulvar leukoplakia
CN109731047A (en) It is a kind of to treat disc herniation, osteoproliferation, rheumatism numbness pain, the arthralgia and myalgia cream of neck-shoulder pain, lumbago and leg pain and preparation method
CN103301403A (en) Chinese medicine composition for treating pain in terminal cancers
CN105999126A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN102343081A (en) Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching
CN104740584A (en) Traditional Chinese medicine composition and acupoint combined acupuncture application for treating chronic gastritis
CN104740193A (en) Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition
CN104784588A (en) Traditional Chinese medicine preparation for treating nerve headache and preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination